Agenus Inc. (AGEN)

2.32
0.11 4.50
NASDAQ : Health Technology
Prev Close 2.43
Open 2.45
Day Low/High 2.34 / 2.48
52 Wk Low/High 2.41 / 6.19
Volume 718.61K
Avg Volume 1.46M
Exchange NASDAQ
Shares Outstanding 104.00M
Market Cap 260.00M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Agenus Discovery Enhances Activity Of Cancer Fighting Antibodies; Findings Published In Cancer Cell

Agenus Discovery Enhances Activity Of Cancer Fighting Antibodies; Findings Published In Cancer Cell

-- Novel discovery improves the immunological activity of certain cancer fighting antibodies

Agenus To Present At The Jefferies 2018 Global Healthcare Conference In New York, NY

Agenus To Present At The Jefferies 2018 Global Healthcare Conference In New York, NY

LEXINGTON, Mass., June 6 , 2018 /PRNewswire/ -- Agenus Inc.

Interesting AGEN Call Options For July 20th

Investors in Agenus Inc saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGEN options chain for the new July 20th contracts and identified the following call contract of particular interest.

Agenus To Present Clinical Data On Lead Programs At ASCO 2018

- AGEN1884 (CTLA-4) and AGEN2034 (PD-1) show objective clinical responses

June 15th Options Now Available For Agenus (AGEN)

June 15th Options Now Available For Agenus (AGEN)

Investors in Agenus Inc saw new options become available today, for the June 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 114 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of AGEN March 16th Options Trading

First Week of AGEN March 16th Options Trading

Investors in Agenus Inc saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGEN options chain for the new March 16th contracts and identified the following call contract of particular interest.

Agenus Announces Combination Clinical Trials Of Its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)

Agenus Announces Combination Clinical Trials Of Its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)

- Combination trial accrual completed in first cohort of patients

Agenus Announces Key Leadership To Advance Combination Trials For Planned BLA Filings

Agenus Announces Key Leadership To Advance Combination Trials For Planned BLA Filings

-- Hagop Youssoufian, MD, named Senior Clinical Strategist

Interesting AGEN Put And Call Options For December 15th

Interesting AGEN Put And Call Options For December 15th

Investors in Agenus Inc saw new options begin trading this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGEN options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

It's All About the Earnings: Cramer's 'Mad Money' Recap (Monday 10/23/17)

It's All About the Earnings: Cramer's 'Mad Money' Recap (Monday 10/23/17)

A not-so-hot-day for the market, says Jim Cramer, but it pays to be optimistic about the stocks of companies that deliver good earnings numbers.

AGEN September 15th Options Begin Trading

AGEN September 15th Options Begin Trading

Investors in Agenus Inc saw new options become available today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGEN options chain for the new September 15th contracts and identified the following put contract of particular interest.

Market's Trading Range Loosens Up

Market's Trading Range Loosens Up

Netflix is the star as S&P, Nasdaq set records.

Agenus Stock Sees Short Interest Decline 14.4%

Agenus Stock Sees Short Interest Decline 14.4%

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 1,600,454 share decrease in total short interest for Agenus Inc , to 9,488,666, a decrease of 14.43% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of February 2018 Options Trading For Agenus (AGEN)

Investors in Agenus Inc saw new options begin trading this week, for the February 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of AGEN November 17th Options Trading

Investors in Agenus Inc saw new options become available this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

These 5 Stocks Under $10 Could Ignite Soon

These 5 Stocks Under $10 Could Ignite Soon

Here's a technical look at how to trade several under-$10 stocks that could break out soon.

Http://www.agenusbio.com

Incyte Corporation (Nasdaq:INCY) and Agenus Inc. (Nasdaq:AGEN) announced today that the companies have amended the License, Development and Commercialization Agreement that was originally entered into January 9, 2015.

Short Interest In Agenus Expands By 11.5%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 1,286,223 share increase in total short interest for Agenus Inc , to 12,447,546, an increase of 11.52% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

These 5 Stocks Under $10 Could Explode Up Soon

These 5 Stocks Under $10 Could Explode Up Soon

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

First Week Of AGEN August 2017 Options Trading

First Week Of AGEN August 2017 Options Trading

Investors in Agenus Inc saw new options become available this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D (Sell)